Rhythm Pharmaceuticals (RYTM) Property, Plant & Equipment (Net) Growth (1y) (2017 - 2026)
Rhythm Pharmaceuticals (RYTM) Property, Plant & Equipment (Net) Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-13.32% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
17.12% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-14.18% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
24.11% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Rhythm Pharmaceuticals |
6.59 Bn |
6.25 Bn |
52.96 Mn |
130.52% |
| Date | Value |
|---|
| Mar 31, 2026 |
130.52% |
| Dec 31, 2025 |
74.68% |
| Sep 30, 2025 |
-70.41% |
| Jun 30, 2025 |
-69.48% |
| Mar 31, 2025 |
-59.79% |
| Dec 31, 2024 |
-52.87% |
| Sep 30, 2024 |
-48.16% |
| Jun 30, 2024 |
-45.12% |
| Mar 31, 2024 |
-42.58% |
| Dec 31, 2023 |
-38.96% |
| Sep 30, 2023 |
-36.31% |
| Jun 30, 2023 |
-30.72% |
| Mar 31, 2023 |
-26.49% |
| Dec 31, 2022 |
-21.90% |
| Sep 30, 2022 |
-17.93% |
| Jun 30, 2022 |
-16.13% |
| Mar 31, 2022 |
-9.45% |
| Dec 31, 2021 |
-11.96% |
| Sep 30, 2021 |
-10.12% |
| Jun 30, 2021 |
-8.41% |
